![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 14, 11323-11334, April 6, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
From Sangamo BioSciences Incorporated,
Richmond, California 94804
We have mapped conserved regions of enhanced
DNase I accessibility within the endogenous chromosomal locus of
vascular endothelial growth factor A (VEGF-A). Synthetic zinc finger
protein (ZFP) transcription factors were designed to target DNA
sequences contained within the DNase I-hypersensitive regions. These
ZFPs, when fused to either VP16 or p65 transcriptional activation
domains, were able to activate expression of the VEGF-A gene as assayed
by mRNA accumulation and VEGF-A protein secretion through a range
exceeding that induced by hypoxic stress. Importantly, multiple splice
variants of VEGF-A mRNA with defined physiological functions were
induced by a single engineered ZFP transcription factor. We present
evidence for an enhanced activation of VEGF-A gene transcription by ZFP transcription factors fused to VP16 and p65 targeted to two distinct chromosomal sites >500 base pairs upstream or downstream of the transcription start site. Our strategy provides a novel approach for
dissecting the requirements for gene regulation at a distance without
altering the DNA sequence of the endogenous target locus.
These authors contributed equally to this work.
§
Present address: Bolder Biotechnology, Inc., Campus Box 347, C.U.-Boulder, Boulder, CO 80309-0347.
¶
To whom correspondence should be addressed: Sangamo
BioSciences Inc., Point Richmond Tech Center, 501 Canal Blvd., Suite
A100, Richmond, CA 94804. Tel.: 510-970-6000 (ext. 216); Fax:
510-236-8951; E-mail: awolffe@sangamo.com.
This article has been cited by other articles:
![]() |
J. Harper, L. Yan, R. M. Loureiro, I. Wu, J. Fang, P. A. D'Amore, and M. A. Moses Repression of Vascular Endothelial Growth Factor Expression by the Zinc Finger Transcription Factor ZNF24 Cancer Res., September 15, 2007; 67(18): 8736 - 8741. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Sander, P. Zaback, J. K. Joung, D. F. Voytas, and D. Dobbs Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool Nucleic Acids Res., July 13, 2007; 35(suppl_2): W599 - W605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Springer, A. Banfi, J. Ye, G. von Degenfeld, P. E. Kraft, S. A. Saini, N. K. Kapasi, and H. M. Blau Localization of vascular response to VEGF is not dependent on heparin binding FASEB J, July 1, 2007; 21(9): 2074 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Meng, S. Thibodeau-Beganny, T. Jiang, J. K. Joung, and S. A. Wolfe Profiling the DNA-binding specificities of engineered Cys2His2 zinc finger domains using a rapid cell-based method Nucleic Acids Res., June 28, 2007; 35(11): e81 - e81. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Mandell and C. F. Barbas III Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases. Nucleic Acids Res., July 1, 2006; 34(Web Server issue): W516 - W523. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Price, C. Dent, B. Duran-Jimenez, Y. Liang, L. Zhang, E. J. Rebar, C. C. Case, P. D. Gregory, T. J. Martin, S. K. Spratt, et al. Gene Transfer of an Engineered Transcription Factor Promoting Expression of VEGF-A Protects Against Experimental Diabetic Neuropathy Diabetes, June 1, 2006; 55(6): 1847 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Tan, Z. Dong, T. A. Wilkinson, C. F. Barbas III, and S. A. Chow Human Immunodeficiency Virus Type 1 Incorporated with Fusion Proteins Consisting of Integrase and the Designed Polydactyl Zinc Finger Protein E2C Can Bias Integration of Viral DNA into a Predetermined Chromosomal Region in Human Cells J. Virol., February 15, 2006; 80(4): 1939 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Durai, M. Mani, K. Kandavelou, J. Wu, M. H. Porteus, and S. Chandrasegaran Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells Nucleic Acids Res., October 26, 2005; 33(18): 5978 - 5990. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dreier, R. P. Fuller, D. J. Segal, C. V. Lund, P. Blancafort, A. Huber, B. Koksch, and C. F. Barbas III Development of Zinc Finger Domains for Recognition of the 5'-CNN-3' Family DNA Sequences and Their Use in the Construction of Artificial Transcription Factors J. Biol. Chem., October 21, 2005; 280(42): 35588 - 35597. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Bhalla Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies J. Clin. Oncol., June 10, 2005; 23(17): 3971 - 3993. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Q. Liu, S. Tan, M. C. Mendel, R. J. Murrills, B. M. Bhat, B. Schlag, R. Samuel, J. J. Matteo, R. de la Rosa, K. Howes, et al. Isogenic Human Cell Lines for Drug Discovery: Regulation of Target Gene Expression by Engineered Zinc-Finger Protein Transcription Factors J Biomol Screen, June 1, 2005; 10(4): 304 - 313. [Abstract] [PDF] |
||||
![]() |
H.-S. Kwon, H.-C. Shin, and J.-S. Kim Suppression of vascular endothelial growth factor expression at the transcriptional and post-transcriptional levels Nucleic Acids Res., April 28, 2005; 33(8): e74 - e74. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Graslund, X. Li, L. Magnenat, M. Popkov, and C. F. Barbas III Exploring Strategies for the Design of Artificial Transcription Factors: TARGETING SITES PROXIMAL TO KNOWN REGULATORY REGIONS FOR THE INDUCTION OF {gamma}-GLOBIN EXPRESSION AND THE TREATMENT OF SICKLE CELL DISEASE J. Biol. Chem., February 4, 2005; 280(5): 3707 - 3714. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Blancafort, D. J. Segal, and C. F. Barbas III Designing Transcription Factor Architectures for Drug Discovery Mol. Pharmacol., December 1, 2004; 66(6): 1361 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tachikawa, O. Schroder, G. Frey, S. P. Briggs, and T. Sera Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins PNAS, October 19, 2004; 101(42): 15225 - 15230. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Segal, J. Goncalves, S. Eberhardy, C. H. Swan, B. E. Torbett, X. Li, and C. F. Barbas III Attenuation of HIV-1 Replication in Primary Human Cells with a Designed Zinc Finger Transcription Factor J. Biol. Chem., April 9, 2004; 279(15): 14509 - 14519. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Q. Liu, M. F. Morton, A. Reik, R. de la Rosa, M. C. Mendel, X.-Y. Li, C. C. Case, C. O. Pabo, V. Moreno, A. Kempf, et al. Cell Lines for Drug Discovery: Elevating Target-Protein Levels Using Engineered Transcription Factors J Biomol Screen, February 1, 2004; 9(1): 44 - 51. [Abstract] [PDF] |
||||
![]() |
W. Tan, K. Zhu, D. J. Segal, C. F. Barbas III, and S. A. Chow Fusion Proteins Consisting of Human Immunodeficiency Virus Type 1 Integrase and the Designed Polydactyl Zinc Finger Protein E2C Direct Integration of Viral DNA into Specific Sites J. Virol., February 1, 2004; 78(3): 1301 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Snowden, L. Zhang, F. Urnov, C. Dent, Y. Jouvenot, X. Zhong, E. J. Rebar, A. C. Jamieson, H. S. Zhang, S. Tan, et al. Repression of Vascular Endothelial Growth Factor A in Glioblastoma Cells Using Engineered Zinc Finger Transcription Factors Cancer Res., December 15, 2003; 63(24): 8968 - 8976. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Carvin, R. D. Parr, and M. P. Kladde Site-selective in vivo targeting of cytosine-5 DNA methylation by zinc-finger proteins Nucleic Acids Res., November 15, 2003; 31(22): 6493 - 6501. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Uil, H. J. Haisma, and M. G. Rots Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities Nucleic Acids Res., November 1, 2003; 31(21): 6064 - 6078. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Bartsevich, J. C. Miller, C. C. Case, and C. O. Pabo Engineered Zinc Finger Proteins for Controlling Stem Cell Fate Stem Cells, November 1, 2003; 21(6): 632 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tan, D. Guschin, A. Davalos, Y.-L. Lee, A. W. Snowden, Y. Jouvenot, H. S. Zhang, K. Howes, A. R. McNamara, A. Lai, et al. Zinc-finger protein-targeted gene regulation: Genomewide single-gene specificity PNAS, October 14, 2003; 100(21): 11997 - 12002. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hurt, S. A. Thibodeau, A. S. Hirsh, C. O. Pabo, and J. K. Joung Highly specific zinc finger proteins obtained by directed domain shuffling and cell-based selection PNAS, October 14, 2003; 100(21): 12271 - 12276. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Easwaran, S. H. Lee, L. Inge, L. Guo, C. Goldbeck, E. Garrett, M. Wiesmann, P. D. Garcia, J. H. Fuller, V. Chan, et al. {beta}-Catenin Regulates Vascular Endothelial Growth Factor Expression in Colon Cancer Cancer Res., June 15, 2003; 63(12): 3145 - 3153. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Reynolds, C. Ullman, M. Moore, M. Isalan, M. J. West, P. Clapham, A. Klug, and Y. Choo Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors PNAS, February 18, 2003; 100(4): 1615 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Papworth, M. Moore, M. Isalan, M. Minczuk, Y. Choo, and A. Klug Inhibition of herpes simplex virus 1 gene expression by designer zinc-finger transcription factors PNAS, February 18, 2003; 100(4): 1621 - 1626. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Sanchez, C. Ullman, M. Moore, Y. Choo, and N.-H. Chua Regulation of Gene Expression in Arabidopsis thaliana by Artificial Zinc Finger Chimeras Plant Cell Physiol., December 15, 2002; 43(12): 1465 - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Guan, J. Stege, M. Kim, Z. Dahmani, N. Fan, P. Heifetz, C. F. Barbas III, and S. P. Briggs Heritable endogenous gene regulation in plants with designed polydactyl zinc finger transcription factors PNAS, October 1, 2002; 99(20): 13296 - 13301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bibikova, M. Golic, K. G. Golic, and D. Carroll Targeted Chromosomal Cleavage and Mutagenesis in Drosophila Using Zinc-Finger Nucleases Genetics, July 1, 2002; 161(3): 1169 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liang, X.-Y. Li, E. J. Rebar, P. Li, Y. Zhou, B. Chen, A. P. Wolffe, and C. C. Case Activation of Vascular Endothelial Growth Factor A Transcription in Tumorigenic Glioblastoma Cell Lines by an Enhancer with Cell Type-specific DNase I Accessibility J. Biol. Chem., May 24, 2002; 277(22): 20087 - 20094. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ren, T. N. Collingwood, E. J. Rebar, A. P. Wolffe, and H. S. Camp PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma 2 but not PPARgamma 1 reactivates adipogenesis Genes & Dev., January 1, 2002; 16(1): 27 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dreier, R. R. Beerli, D. J. Segal, J. D. Flippin, and C. F. Barbas III Development of Zinc Finger Domains for Recognition of the 5'-ANN-3' Family of DNA Sequences and Their Use in the Construction of Artificial Transcription Factors J. Biol. Chem., July 27, 2001; 276(31): 29466 - 29478. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |